Skip to content

New Cobe Cardioplegia System

by Cobe Cardiovascular, Inc.

510(k) K920312

Active United States

510(k)

Valid until

No expiry

510(k) clearance is not time-limited

FDA recalls

None found

in data synced 22 Oct 2026

Documents

Trust

Unverified

Registry data, not yet checked by deviCERTS. Source FDA 510(k), synced 22 Oct 2026. What this means

Regulatory status

as of registry sync 22 Oct 2026

RegionAuthorizationNumberDateStatus
United StatesFDA 510(k)SESE Substantially Equivalent · Traditional NumberK920312 Date1 Oct 1992ClearedStatusActive

Recalls

0 recalls · FDA

No FDA recalls found in the data synced 22 Oct 2026.

Coverage

1 jurisdiction

United States of America
  • Active
  • Expiring
  • Withdrawn
  • Listed
  • Not covered

United States — FDA 510(k) Active

Specification

510(k)

510(k) Number
FDA Product Code
DTN
Device Class
Class II
Regulation
21 CFR Part 870.4400
Advisory Committee
Cardiovascular
FDA Decision
SESE Substantially Equivalent

Overview

AI-generated summary, 1 Oct 2026

Written by a language model from registry data. Not verified by deviCERTS or the manufacturer. The registry data above is the record.

The New Cobe Cardioplegia System is a Reservoir, Blood, Cardiopulmonary Bypass device designed for cardiopulmonary support during cardiac surgical procedures. It delivers cardioplegic solutions to arrest and protect the heart during open-heart surgery by maintaining myocardial perfusion and metabolic stability. The system integrates with extracorporeal circulation to ensure controlled delivery of cold or warm cardioplegia, reducing ischemic injury and improving postoperative recovery outcomes.

This device is intended for use in sterile surgical settings and is supplied as a reusable system, requiring proper cleaning, disinfection, and maintenance per manufacturer guidelines. It is classified as Class II under FDA regulations (21 CFR 870.4400) and holds a 510(k) clearance (K920312) for traditional pathways in cardiovascular applications. Compatibility with MRI environments is not specified, and its operation adheres to standard cardiopulmonary bypass protocols, with no single-use components noted in the regulatory data.

Other devices from Cobe Cardiovascular, Inc.

See all devices from Cobe Cardiovascular, Inc. →

Questions

AI-generated answers, 1 Oct 2026

Written by a language model from registry data. Not verified by deviCERTS or the manufacturer. The registry data above is the record.

  • What is the Cobe Cardioplegia System used for?

    The Cobe Cardioplegia System is designed for cardiopulmonary support during cardiac surgical procedures. It delivers cardioplegic solutions to arrest and protect the heart by maintaining myocardial perfusion and metabolic stability, thereby reducing ischemic injury and improving postoperative recovery outcomes.

  • Is the Cobe Cardioplegia System reusable or single-use?

    The Cobe Cardioplegia System is a reusable device. It requires proper cleaning, disinfection, and maintenance as outlined by the manufacturer to ensure safe and effective use in sterile surgical settings.

  • What type of cardioplegia does this system support?

    The system supports the delivery of both cold and warm cardioplegia, allowing clinicians to choose the appropriate temperature for their surgical procedure to optimize myocardial protection.

  • Are there any specific storage requirements for this device?

    While the provided data does not specify detailed storage instructions, the Cobe Cardioplegia System is intended for use in sterile surgical environments. It should be stored and maintained according to the manufacturer’s guidelines to preserve its functionality and ensure sterility before use.

  • What regulatory pathway does this device follow?

    The Cobe Cardioplegia System holds a 510(k) clearance (K920312) under the FDA’s traditional pathway and is classified as a Class II device under 21 CFR 870.4400. This classification applies to its use in cardiopulmonary bypass and cardioplegia delivery during cardiac surgery.